Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • cacti
    Member
    • Jan 2014
    • 12

    Multiple files with same barcode in TCGA

    Does anyone know what differentiates the bam files from samples with the same barcode? in TCGA For example, this sample (TCGA-D7-8575-01A-11D-2340-08) has files *.5.bam and *.1.bam. What is the difference?


    C440.TCGA-D7-8575-01A-11D-2340-08.5.bam
    C1646.TCGA-D7-8575-01A-11D-2340-08.1.bam
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #2
    It's some kind of version number; they appear to be exclusively associated with "BI", broad institute.
    It's not clear whether newer ones are replacing the previous version or if they are a separate run and are therefore additional information.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Not an answer for your question but see this link: https://browser.cghub.ucsc.edu/searc...1A-11D-2340-08 If you scroll over to the right in the table you can see that there are 2 live files. If you click on the "i" symbol you can get additional information (choose "show details in new window"). These may be two separate runs for the sample looking at the submission date.

      Comment

      • m_two
        Member
        • Mar 2010
        • 50

        #4
        The same aliquot may have been sequenced multiple times and/or processed multiple times:

        Some aliquots have been sequenced for VALIDATION, WGS, and WXS
        Some aliquots have been captured with different probe sets.

        Some data may have been aligned to NCBI36, GRCh37, and GRCh38.

        Some data have had additional reads added or removed after the version used in a publication was generated so both versions are live.

        You can query CGHub for these details:

        library_type
        assembly
        published
        uploaded
        modified
        state
        reason
        reagent_vendor
        reagent_name

        or pull them from columns 1,8,13,23-26,31-33 of the MANIFEST at

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:41 AM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        45 views
        0 reactions
        Last Post SEQadmin2  
        Working...